Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BYCureus

Factors Associated With Recurrence in Patients With Benign Paroxysmal Positional Vertigo Following Canal Repositioning Therapy.

  1. 1Department of Otorhinolaryngology, Guru Gobind Singh Medical College and Hospital, Faridkot, IND.

Abstract

Benign paroxysmal positional vertigo (BPPV) is effectively managed with canal repositioning therapy; however, recurrence is common. Identifying clinical factors associated with recurrence may help improve follow-up and patient counselling. This study aimed to determine the recurrence of BPPV following canal repositioning therapy and to evaluate the demographic and clinical factors associated with recurrence. This prospective observational study included 100 patients with clinically diagnosed BPPV who underwent canal repositioning therapy in the Department of Otorhinolaryngology at Guru Gobind Singh Medical College and Hospital, Faridkot. Demographic characteristics, comorbidities, clinical presentation, affected side, and involved semicircular canal were recorded for all patients. Patients were followed up for recurrence, and potential predictors were evaluated using univariate logistic regression analysis. Recurrence occurred in 27 (27.0%) patients, whereas 73 (73.0%) remained recurrence-free during follow-up. Posterior canal involvement was predominant in both groups. Hypertension and diabetes mellitus were significantly associated with recurrence in univariate analysis, whereas sex, affected side, and involved semicircular canal were not significantly associated with recurrence. Among patients who developed recurrence, 12 (44.4%) experienced recurrence within one month, 10 (37.0%) between one and three months, and 5 (18.5%) between three and six months. Recurrence following canal repositioning therapy was significantly associated with hypertension and diabetes mellitus in the present study. Recognition of these factors may support individualized counselling and closer follow-up of patients at greater risk of recurrence.

Related

  1. Efficacy and safety of spleen-strengthening and phlegm-resolving herbal therapy for residual dizziness after repositioning of benign paroxysmal positional vertigo: a systematic review and meta-analysis of randomized controlled trials
    Yuqi Zhang, Yingqiu Sun, Qingxiao Li +4
    Frontiers in medicinePeer-reviewedCC BYFull textNeurologyEurope PMCPMCEurope PMC
  2. Beat-to-Beat Nystagmus Differentiation Between Benign Paroxysmal Positional Vertigo (BPPV) and Vestibular Migraine (VM): A Cross-Sectional Videonystagmographic Study From Northern India
    Pratishtha Sachan, Srinivas Dorasala, Utkarsh Bansal +4
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Video Head Impulse Test in the Diagnosis of Benign Paroxysmal Positional Vertigo: A Systematic Review of the Literature.
    Luigi Califano, Salvatore Martellucci, Maria Grazia Melillo +1
    Audiology researchPeer-reviewedCC BYFull textNeurologyEurope PMC
  4. Successful Bailout Retrieval of an Active‐Fixation Atrial Leadless Pacemaker Following Suspected Tissue Entrapment During Repositioning
    Toshiya Yoshida, Akira Kasagawa, Daisuke Togashi +2
    Journal of arrhythmiaPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. The Relationship Between Serum Vitamin D Levels and the First-Attempt Success of the Epley Maneuver in Posterior Canal Benign Paroxysmal Positional Vertigo (PC-BPPV)
    Akif Sinan Bilgen, Ali Yalçindağ, Özlem Akkoca +5
    Journal of clinical medicinePeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
BibTeX
@article{kaur2026factors,
  title = {{Factors Associated With Recurrence in Patients With Benign Paroxysmal Positional Vertigo Following Canal Repositioning Therapy.}},
  author = {Navdeep Kaur and Rachna Dhingra and Sumit Prinja},
  journal = {Cureus},
  year = {2026},
  month = sep,
  doi = {10.7759/cureus.117036},
  url = {https://europepmc.org/article/MED/42952925},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Factors Associated With Recurrence in Patients With Benign Paroxysmal Positional Vertigo Following Canal Repositioning Therapy.
AU  - Navdeep Kaur
AU  - Rachna Dhingra
AU  - Sumit Prinja
PY  - 2026
DA  - 2026/09/27
JO  - Cureus
DO  - 10.7759/cureus.117036
UR  - https://europepmc.org/article/MED/42952925
AB  - Benign paroxysmal positional vertigo (BPPV) is effectively managed with canal repositioning therapy; however, recurrence is common. Identifying clinical factors associated with recurrence may help improve follow-up and patient counselling. This study aimed to determine the recurrence of BPPV following canal repositioning therapy and to evaluate the demographic and clinical factors associated with recurrence. This prospective observational study included 100 patients with clinically diagnosed BPPV who underwent canal repositioning therapy in the Department of Otorhinolaryngology at Guru Gobind Singh Medical College and Hospital, Faridkot. Demographic characteristics, comorbidities, clinical presentation, affected side, and involved semicircular canal were recorded for all patients. Patients were followed up for recurrence, and potential predictors were evaluated using univariate logistic regression analysis. Recurrence occurred in 27 (27.0%) patients, whereas 73 (73.0%) remained recurrence-free during follow-up. Posterior canal involvement was predominant in both groups. Hypertension and diabetes mellitus were significantly associated with recurrence in univariate analysis, whereas sex, affected side, and involved semicircular canal were not significantly associated with recurrence. Among patients who developed recurrence, 12 (44.4%) experienced recurrence within one month, 10 (37.0%) between one and three months, and 5 (18.5%) between three and six months. Recurrence following canal repositioning therapy was significantly associated with hypertension and diabetes mellitus in the present study. Recognition of these factors may support individualized counselling and closer follow-up of patients at greater risk of recurrence.
SN  - 2168-8184
ER  -